Thomas Millonig

LunGuard Ltd. develops physiological integrated patient interface system for ICU ventilated and fed patients. It offers Reflux Prevention System, GI tract disposable, respiratory system disposable and closing nutritional loop services. The company was founded by Ofer Pintel and Moshe Dayan in January 2009 and is headquartered in Omer, Israel.

Attenti EM Ltd. engages in providing of wide-ranging remote monitoring technologies. The company was founded by Michael Goldstein in 1990 and is headquartered in Tel Aviv, Israel.

Part of Deutsche Post AG, DHL ISC (Hong Kong) Ltd. is a Chinese company that provides warehousing and storage of a general line of goods. The company is based in Hong Kong, Hong Kong.

Check Point SpA operates as sporting goods stores. It offers all types of sporting goods under the brand Streetware Fashion, Fashion UOMO and Fashion DONNA. The company is headquartered in Asola, Italy

NILIT Ltd. manufactures and markets nylon polyamide fibers. It specializes in polymerization, compounding, spinning, and texturing. The firm offers products and services for apparel and engineering thermoplastics applications. The company was founded by Ennio Levi in 1969 and is headquartered in Migdal Haemek, Israel.

Medasense Biometrics Ltd. develops pain monitoring devices. The firm is a medical device company that develops a continuous and non-invasive pain-monitoring device. The company was founded by Galit Zuckerman and Itay Goor-Aryeh in 2008 and is headquartered in Ramat Yishai, Israel.

StoreDot Ltd. develops biological semiconductors. It provides bio-organic Nanodots, a micro-crystals of uniform size and consist of peptide molecules applied on mobile displays and energy storage devices and used for coating of batteries and supercapacitors of mobile phones. The company was founded by Doron Myersdorf, Simon Litsyn and Gil Rosenman in 2012 and is headquartered in Herzeliya, Israel.

Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland.

New N.I. Medical (2011) Ltd. provides a non-invasive cardiac output monitoring system called nicas, which helps manage hypertension, dialysis, and heart failure. The private company is based in Raanana, Israel and was founded in 2011. The system is easy to use, cost-effective, and provides accurate assessment of cardiovascular, respiratory, and fluid status. The Israeli company's flagship solution, nicas, is based on advanced, proprietary patented technology and is designed to be the preferred solution for various challenges in cardiovascular disease management. The CEO is Eyal Karev.

OurCrowd Management Ltd (OurCrowd Management) is a venture capital firm and equity based crowdfunding platform founded in 2013 by Jonathan Medved and Steven Blumgart. The firm is headquartered in Jerusalem, Israel.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

Part of OurCrowd Management Ltd., OurCrowd Squared LP acts as a private equity fund. The company is based in Jerusalem, Israel.

Nanox Imaging Plc operates in the healthcare sector. The company is headquartered in Gibraltar.

Illumigyn Ltd. is a bio technology company. Its product Gynescope is an advanced (patented) imaging colposcope that delivers down to 15 micron image resolution over a wide field of view and a range of working distances, coupled with multispectral illumination options, in order to reduce the inherent subjectivity of colposcopy and cervical exams thus enabling early detection of cervical cancer while meaningfully reducing misdiagnosis. The company was founded by Lior Greenstein in 2012 and is headquartered in Neve Ilan, Israel.

S.D. Sight Diagnostics Ltd. develops medical devices for diagnosing blood diseases. Its product, the Parasight platform, is the automated microscopy device for Malaria diagnosis. The company was founded by Joseph Joel Pollak in 2011 and is headquartered in Tel Aviv, Israel.

Part of Ziegler Meditech Partners LLC, Meditech Advisors Management LLC acts as a special purpose vehicle.

Quescon Consultants Ltd. provides medical device consulting services. The private company is based in Jerusalem, Israel. The Israeli company was founded in 2012. Samuel Morry Blumenfeld has been the CEO of the company since 2012.

Itamar Medical, Inc. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the diagnosis of cardio logical conditions and sleep breathing disorders. The company is headquartered in Atlanta, GA.

Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.

Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.

Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom.

Synthesis Capital is a venture capital firm founded in 2007. The firm is headquartered in Boston, Massachusetts.

Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel.

National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.